Categories: Wire Stories

Ketamine Clinic in Japan for Inbound Medical Treatment: Nagoya Anesthesia Clinic

NAGOYA, Japan–(BUSINESS WIRE)–Nagoya Anesthesia Clinic (https://nagoyamasui.com/2-2), located in Nagoya City, Aichi Prefecture, Japan, has initiated inbound medical treatment for treatment-resistant depression, other mental disorders, and intractable chronic pain, utilizing the groundbreaking drug Ketamine. Over the past 15 years, the clinic has provided ketamine therapy through more than 1300 ketamine infusions. Our distinctive approach to addressing pain and depression includes a simultaneous cervical epidural block, with successful implementation in over 250 cases, and hypnotherapy during ketamine infusion. Additionally, the clinic offers innovative procedures such as Echo-Guided Botox treatment for stiff neck and Echo-Guided PRP therapy for tennis elbow.


Ketamine, a widely used general anesthetic with a history dating back over 50 years, has also been employed in the United States for the treatment of mental disorders and chronic pain for the past decade. Unlike conventional medications, which may take time to alleviate symptoms, Ketamine offers rapid relief within hours to up to three weeks of administration. Moreover, it is associated with minimal long-term side effects, making it a promising treatment option.

Drawing on their extensive experience of performing Ketamine infusions for various pain and mental disorders, Nagoya Anesthesia Clinic has established the Ketamine Clinic based on Ketamine’s potent analgesic and antidepressant properties. Typically, ketamine infusions are administered in sets of 3 to 6 sessions over a span of 1 to 3 weeks, followed by a maintenance therapy once a month, known for its low incidence of long-term side effects.

Nagoya Anesthesia Clinic is dedicated to provision of exceptional care and innovative treatments to patients in Japan and beyond, welcoming patients for inbound medical treatment of treatment-resistant depression, OCD, PTSD, and intractable chronic pain starting from October 2023. Building on their extensive ketamine infusion experience, the clinic aims to support individuals coping with treatment-resistant conditions through innovative, evidence-based, and compassionate approaches.

 

Contacts

For inquiries, please contact:

JTB Medical & Healthcare:

jmhc_info@j-medical-healthcare.com

Alex

Recent Posts

Fushi Technology to Launch AI Agent Industry Vertical Applications, Accelerating Southeast Asia Market Expansion

HONG KONG SAR - Media OutReach Newswire - 22 December 2024 - On December 20th,…

7 hours ago

Step into Hong Kong: Experience the “Immersive Hong Kong” Exhibition in Dubai

HONG KONG SAR - Media OutReach Newswire - 20 December 2024 - The "Immersive Hong…

2 days ago

ZJLD Awarded the 2024 Hong Kong Corporate Governance and ESG Excellence Award by the Chamber of Hong Kong Listed Companies

HONG KONG SAR - Media OutReach Newswire - 20 December 2024 - The first baijiu…

2 days ago

Japan’s first overseas JOYPOLIS SPORTS flagship complex opens in Kai Tak Sports Park

The all-weather indoor sportainment complex, JOYPOLIS SPORTS HONG KONG, grandly opens today. With five stories…

2 days ago

XTransfer and OCBC Jointly Announce Comprehensive Partnership

"Global Multi-Currency Accounts" Empowers SMEs with New Market Opportunities SHANGHAI, CHINA - Media OutReach Newswire…

3 days ago

XTransfer and OCBC Jointly Announce Comprehensive Partnership

"Global Multi-Currency Accounts" Empowers SMEs with New Market Opportunities SHANGHAI, CHINA - Media OutReach Newswire…

3 days ago